President Donald Trump hinted at the possibility of the United States rejoining the World Health Organization (WHO), days after initiating the country’s withdrawal. Speaking at a rally in Las Vegas, Trump stated, “Maybe we would consider doing it again... They would have to clean it up.” The U.S. is set to leave the WHO on January 22, 2026, following Trump’s decision after being sworn in for a second term.
Trump criticized the WHO’s handling of the COVID-19 pandemic and other global health crises, expressing frustration that the U.S. contributes significantly more funding than China despite its smaller population. The U.S. currently accounts for approximately 18% of the WHO’s $6.8 billion budget for 2024-2025, making it the organization’s largest financial supporter.
In his speech, Trump also discussed expanding economic ties with Saudi Arabia. He shared that Crown Prince Mohammed bin Salman recently pledged $600 billion in investments and trade over the next four years. Trump said he aims to increase this figure to $1 trillion to boost the U.S. economy.
Trump’s remarks highlight his focus on prioritizing U.S. interests in international organizations and partnerships. Whether the U.S. returns to the WHO will likely depend on reforms addressing Trump’s concerns over funding disparities and operational efficiency.
These developments come as Trump seeks to reshape global alliances while emphasizing stronger investment ties with key partners like Saudi Arabia.


Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
UAE Plans Temporary Housing Complex for Displaced Palestinians in Southern Gaza
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Trump Signs “America First Arms Transfer Strategy” to Prioritize U.S. Weapons Sales
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Nighttime Shelling Causes Serious Damage in Russia’s Belgorod Region Near Ukraine Border
Trump Allegedly Sought Airport, Penn Station Renaming in Exchange for Hudson River Tunnel Funding
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 



